The bulk pack of king crab legs follows the trend of enormous food volumes, presenting an impressive option for seafood lovers seeking both quality and quantity. These crab legs come in 9 to 12 ounce ...

Sign up for a trial to have full access to our articles for 7 days!

The FDA has scuttled Merus’ plans to win a speedy approval for its solid tumor drug zenocutuzumab. On the cusp of the priority review deadline, the agency has pushed back the decision date by ...

Nov 5 (Reuters) - The U.S. Food and Drug Administration on Tuesday extended the review of Merus' gene-targeting cancer therapy to allow sufficient time to assess some recent information submitted ...

Revenue: US$11.8m (up 6.7% from 3Q 2023). Net loss: US$99.9m (loss widened by 334% from 3Q 2023). US$1.46 loss per share (further deteriorated from US$0.43 loss in 3Q 2023). Revenue exceeded ...

Merus N.V. (NASDAQ:MRUS) is gearing up for a major milestone with respect to regulatory approval of its drug zenocutuzumab for the treatment of patients with NRG1 positive [NRG1+] non-small cell ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merus on Tuesday said the Food and Drug Administration extended its review of the clinical-stage oncology company's proposed zenocutuzumab cancer treatment. Merus said the FDA set a new target ...

The U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for the review of Merus N.V.'s (NASDAQ:MRUS) Biologics License Application (BLA ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, ...